China Jo-Jo Drugstores, Inc. Sample Contracts

China Jo-Jo Drugstores, Inc. – AMENDMENT NO. 5 TO THE CHINA JO-JO DRUGSTORES, INC. 2010 EQUITY INCENTIVE PLAN (February 14th, 2019)

WHEREAS, China Jo-Jo Drugstores, Inc. (the “Company”) maintains the China Jo-Jo Drugstores, Inc. 2010 Equity Incentive Plan (the “Plan”); and

China Jo-Jo Drugstores, Inc. – INDENTURE Dated as of ____________, 20__ Between China Jo-Jo Drugstores, Inc. as Issuer And as Trustee Debt Securities (October 26th, 2018)

INDENTURE dated as of __________, 20___, between China Jo-Jo Drugstores, Inc., a Nevada corporation (the “Company”), as issuer, and [_______________], a [__________] banking corporation, as Trustee (the “Trustee”).

China Jo-Jo Drugstores, Inc. – CareRetail (HK) Holdings Limited Joint Venture Contract On Zhejiang Jiusong Pharmaceutical Management Co., Ltd. Made By and Between CareRetail (HK) Holdings Limited And Hangzhou Jiuzhou Grand Pharmacy Co., Ltd. 目录 Contents (February 10th, 2017)

本合资经营合同(下称“本合同”)由以下双方于2017年1月 18 日在中国杭州签署: This Joint Venture Contract (hereinafter referred to as “this Contract”) is signed in Hangzhou, China on January 18, 2017 by and between:

China Jo-Jo Drugstores, Inc. – SECURITIES PURCHASE AGREEMENT (January 4th, 2017)

This Securities Purchase Agreement (this “Agreement”) is dated as of January 3, 2017, between China Jo-Jo Drugstores, Inc., a Nevada corporation (the “Company”), and CareRetail Holdings Limited, an exempt company incorporated under the laws of the Cayman Islands (the “Purchaser” ).

China Jo-Jo Drugstores, Inc. – INVESTOR RIGHTS AGREEMENT dated as of January 3, 2017 among China Jo-Jo Drugstores, Inc., CARERETAIL HOLDINGS LIMITED and CERTAIN OTHER PARTIES NAMED HEREIN (January 4th, 2017)

INVESTOR RIGHTS AGREEMENT, dated as of January 3, 2017 (this “Agreement”), among (1) China Jo-Jo Drugstores, Inc., a company incorporated under the laws of the State of Nevada (the “Company”), (2) Hangzhou Jiuzhou Grand Pharmacy Chain Co., Ltd. (杭州九洲大药房连锁有限公司), a company organized under the laws of the PRC (“Jiuzhou Grand Pharmacy” or the “VIE”), (3) Lei Liu (“Mr. Liu”), (4) Li Qi (“Ms. Qi,” and together with Mr. Liu, the “Founders”), (5) Super Marvel Limited, a company incorporated under the laws of the British Virgin Islands (“Founders SPV,” and together with the Founders, the “Founder Parties”) and (6) CareRetail Holdings Limited, an exempt company organized under the laws of the Cayman Islands (the “Investor”).

China Jo-Jo Drugstores, Inc. – CHINA JO-JO DRUGSTORES, INC. RESTRICTED STOCK AWARD AGREEMENT UNDER THE 2010 EQUITY INCENTIVE PLAN (December 2nd, 2015)

Pursuant to the China Jo-Jo Drugstores, Inc. 2010 Equity Incentive Plan (the “Plan”) as amended through the date hereof, China Jo-Jo Drugstores, Inc. (the “Company”) hereby grants a Restricted Stock Award (an “Award”) to the Grantee named above.  Upon acceptance of this Award, the Grantee shall receive the number of shares of common stock of the Company, par value $.001 per share (“Par Value”), specified above (the “Shares”) having a fair value per share (“Original Value”) equal to the amount specified above, subject to the restrictions and conditions set forth herein and in the Plan.  The Company acknowledges the receipt from the Grantee of consideration with respect to the Original Value of the Shares in the form of cash, past or future services rendered by the Grantee to the Company, a subsidiary of the Company and/or an affiliated or related entity which the Company controls (the “Company”), or such other form of consideration as is acceptable to the Committee.

China Jo-Jo Drugstores, Inc. – China Jo-Jo Drugstores Reports Second Quarter Fiscal Year 2016 Financial Results (November 12th, 2015)

HANGZHOU, China, Nov. 12, 2015 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ CM: CJJD) (the "Company" or "China Jo-Jo"), a leading China-based pharmacy with retail, wholesale and online distributor of pharmaceutical and health care products through its own online and retail pharmacies, today announced financial results for the second-quarter ended September 30, 2015.

China Jo-Jo Drugstores, Inc. – SECURITIES PURCHASE AGREEMENT (July 21st, 2015)

This Securities Purchase Agreement (this “Agreement”) is dated as of July 19, 2015, between China Jo-Jo Drugstores, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

China Jo-Jo Drugstores, Inc. – COMMON STOCK PURCHASE WARRANT china jo-jo drugstores, inc. (July 21st, 2015)

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after January __, 2016 (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from China Jo-Jo Drugstores, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

China Jo-Jo Drugstores, Inc. – July 19, 2015 STRICTLY CONFIDENTIAL Attn: Mr. Lei Liu M.D. 1st Floor, Yuzheng Plaza, No. 76, Yuhuangshan Road Hangzhou, Zhejiang Province People’s Republic of China Dear Mr. Liu: (July 21st, 2015)

This letter agreement (this “Agreement”) constitutes the agreement between China JO-JO Drugstores, Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”) that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (“Securities”) during the Term (as defined below) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of Wainwright in con

China Jo-Jo Drugstores, Inc. – CHINA JO-JO DRUGSTORES, INC. RESTRICTED STOCK AWARD AGREEMENT UNDER THE 2010 EQUITY INCENTIVE PLAN (November 24th, 2014)

Pursuant to the China Jo-Jo Drugstores, Inc. 2010 Equity Incentive Plan (the “Plan”) as amended through the date hereof, China Jo-Jo Drugstores, Inc. (the “Company”) hereby grants a Restricted Stock Award (an “Award”) to the Grantee named above.  Upon acceptance of this Award, the Grantee shall receive the number of shares of common stock of the Company, par value $.001 per share (“Par Value”), specified above (the “Shares”) having a fair value per share (“Original Value”) equal to the amount specified above, subject to the restrictions and conditions set forth herein and in the Plan.  The Company acknowledges the receipt from the Grantee of consideration with respect to the Original Value of the Shares in the form of cash, past or future services rendered by the Grantee to the Company, a subsidiary of the Company and/or an affiliated or related entity which the Company controls (the “Company”), or such other form of consideration as is acceptable to the Committee.

China Jo-Jo Drugstores, Inc. – NON- Statutory STOCK OPTION AGREEMENT pursuant to the 2010 EQUITY INCENTIVE PLAN OF CHINA JO-JO DRUGSTORES, INC. (November 24th, 2014)

THIS NON- Statutory STOCK OPTION AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between China Jo-Jo Drugstores, Inc., a Nevada corporation (the “Company”), and the Optionee specified above, pursuant to the 2010 Equity Incentive Plan of the Company, as in effect and as amended from time to time (the “Plan”); and

China Jo-Jo Drugstores, Inc. – Corporate Acquisition Contract (November 13th, 2014)
China Jo-Jo Drugstores, Inc. – INDENTURE Dated as of ____________, 20__ Between China Jo-Jo Drugstores, Inc. as Issuer And as Trustee Debt Securities (August 8th, 2014)

INDENTURE dated as of __________, 20___, between China Jo-Jo Drugstores, Inc., a Nevada corporation (the “Company”), as issuer, and [_______________], a [__________] banking corporation, as Trustee (the “Trustee”).

China Jo-Jo Drugstores, Inc. – House Lease Agreement (June 27th, 2014)

In accordance with the provisions by the Contract Law of the People's Republic of China and the relevant laws and regulations and based on the principle of equality, mutual benefit and voluntariness, Party A and Party B reach the following agreement for the leasing matters of “Yuzheng Commercial Building”:

China Jo-Jo Drugstores, Inc. – CHINA JO-JO DRUGSTORES, INC. Room 507-513, 5th Floor A Building Meidu Plaza Gongshu District, Hangzhou Zhejiang Province, People’s Republic of China Tel: + 86 (571) 88077078 December 6, 2013 (December 12th, 2013)

China Jo-Jo Drugstores, Inc., a Nevada corporation (the “Company”), is pleased to offer you a non-executive director position on its Board of Directors (the “Board”).  The Board’s purpose is to oversee or direct the property, affairs and business of the Company.

China Jo-Jo Drugstores, Inc. – China Jo-Jo Drugstores, Inc. Reports Fiscal Year 2014 First Quarter Earnings Results and Schedules Conference Call for August 19, 2013 (August 16th, 2013)

China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in China, today reported earnings results for the three months ended June 30, 2013. The Company will hold a conference call on Monday, August 19, 2013, at 8:00 a.m. Eastern Time. Please see below for dial-in information.

China Jo-Jo Drugstores, Inc. – China Jo-Jo Drugstores, Inc. Reports Fiscal Year 2013 Earnings Results and Schedules Conference Call for July 5, 2013 (July 2nd, 2013)

China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in China, today reported earnings results for the fiscal year ended March 31, 2013.  The Company will hold a conference call on Friday, July 5, 2013, at 8:00 a.m. Eastern Time. Please see below for dial-in information.

China Jo-Jo Drugstores, Inc. – China Jo-Jo Drugstores, Inc. Receives Delisting Notice from NASDAQ (May 13th, 2013)

HANGZHOU, China--(PR NEWS WIRE)--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in China, today announced that on May 9, 2013, it was notified by The NASDAQ Stock Market LLC (“NASDAQ”), notifying it of its failure to maintain a minimum closing bid price of $1.00 over the then preceding 30 consecutive trading days for its common stock as required by NASDAQ Listing Rule 5550(a)(2).  The Company has until November 5, 2013, to regain compliance.

China Jo-Jo Drugstores, Inc. – CHINA JO-JO DRUGSTORES REPORTS THIRD QUARTER EARNINGS RESULTS (February 15th, 2013)

HANGZHOU, China--(BUSINESS WIRE)--China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD), (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in Zhejiang and Shanghai, today reported earnings results for the third quarter of fiscal 2013 ended December 31, 2012. The Company will hold its earnings call on Tuesday, February 19, 2013, at 8:00 a.m. Eastern Time. Please see below for dial in information.

China Jo-Jo Drugstores, Inc. – CHINA JO-JO DRUGSTORES, INC. (January 4th, 2013)

China Jo-Jo Drugstores, Inc., a Nevada corporation (the “Company”), is pleased to offer you a non-executive director position on its Board of Directors (the “Board”).  The Board’s purpose is to oversee or direct the property, affairs and business of the Company.

China Jo-Jo Drugstores, Inc. – CONSULTING SERVICES AGREEMENT (January 4th, 2013)

This Consulting Services Agreement (the “Agreement”), dated as of January 1, 2013 (the “Effective Date”), is entered into by and between China Jo-Jo Drugstores, Inc. (the “Company”), a Nevada corporation having its principal executive office at Room 507-513, 5th Floor, A Building, Meidu Plaza Gongshu District, Hangzhou, Zhejiang Province People’s Republic of China, and Worldwide Officers, Inc., a California corporation having its principal place of business at 6571 Morningside Drive  Huntington Beach, California  92648 (“Consultant”).

China Jo-Jo Drugstores, Inc. – CHINA JO-JO DRUGSTORES, INC. Room 507-513, 5th Floor A Building Meidu Plaza Gongshu District, Hangzhou Zhejiang Province, People’s Republic of China Tel: + 86 (571) 88077078 (November 30th, 2012)
China Jo-Jo Drugstores, Inc. – China Jo-Jo Drugstores Inc. Reports Financial Results For Second Quarter Fiscal 2013 and Announces Second Quarter Fiscal 2013 Conference Call (November 14th, 2012)

China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD), (the "Company"), a retail and wholesale distributor of pharmaceutical and other healthcare products in Zhejiang and Shanghai, today reported earnings results for the second quarter of fiscal 2013 ended September 30, 2012. The Company will hold its second quarter fiscal 2013 earnings call on Friday, November 16, 2011 at 8:00 a.m. Eastern Time. Please see below for dial in information.

China Jo-Jo Drugstores, Inc. – China Jo-Jo Drugstores, Inc. Receives Delisting Notice from NASDAQ (September 6th, 2012)

HANGZHOU, China--(BUSINESS WIRE)--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in China, today announced that on August 31, 2012, it was notified by The NASDAQ Stock Market LLC (“NASDAQ”), notifying it of its failure to maintain a minimum closing bid price of $1.00 over the then preceding 30 consecutive trading days for its common stock as required by NASDAQ Listing Rule 5550(a)(2).  The Company has until February 27, 2013, to regain compliance.

China Jo-Jo Drugstores, Inc. – China Jo-Jo Drugstores, Inc. Reports Fiscal First Quarter 2013 Revenue and Schedules First Quarter FY 2013 Conference Call Business Wire HANGZHOU, China -- August 14, 2012 (August 14th, 2012)

China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD), (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in Zhejiang and Shanghai, today reported earnings results for the first quarter of fiscal 2013 ended June 30, 2012.

China Jo-Jo Drugstores, Inc. – China Jo-Jo Drugstores, Inc. Reports Fiscal Year 2012 Earnings Results and schedules conference call for July 3, 2012 Fiscal Year 2012 Highlights: --Revenues reached record $94.4 million --Gross profit rose 30% to $27.6 million, gross margin 29% --Sales from the cultivation of Traditional Chinese Medicines were $4.2 million, from online drug sales was $1.1 million --Net income $8.1 million --Diluted and basic earnings per share of $0.60 --Completed integration of a licensed drug wholesaler (July 2nd, 2012)

China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in China, today reported earnings results for the fiscal year ended March 31, 2012. The Company will hold a conference on Tuesday, July 3, 2012, at 8:00 a.m. Eastern Time. Please see below for dial-in information.

China Jo-Jo Drugstores, Inc. – CONSULTING SERVICES AGREEMENT (May 17th, 2012)

This Consulting Services Agreement (this “Agreement”) is dated May 15, 2012, and is entered into in Hangzhou City, People’s Republic of China (“PRC” or “China”) by and between Zhejiang Jiuxin Investment Management Co., Ltd (“Party A”) and Zhejiang Jiuying Grand Pharmacy Co., Ltd. (“Party B”). Party A and Party B are referred to collectively in this Agreement as the “Parties.”

China Jo-Jo Drugstores, Inc. – OPTION AGREEMENT (May 17th, 2012)

This Option Agreement (this “Agreement”) is dated May 15, 2012, and is entered into in Hangzhou City, People’s Republic of China (“PRC” or “China”) by and among Zhejiang Jiuxin Investment Management Co., Ltd (“Party A”) and Zhejiang Jiuying Grand Pharmacy Co., Ltd. (“Company” or “Party B”), the individual shareholders collectively holding 51% of the issued and outstanding equity interests of Party B (i.e. LIU Lei, JIN Chong’an and QI Li, each as a “Individual Shareholder” and collectively as “Party C”), and Zhejiang Shouantang Medical Technology Co., Ltd (“Party D”).  Party A, Party B, Party C and Party D are each referred to in this Agreement as a “Party” and collectively as the “Parties.” Party D is made a party hereto for the sole purpose of acknowledging this Agreement.

China Jo-Jo Drugstores, Inc. – EQUITY PLEDGE AGREEMENT (May 17th, 2012)

This Equity Pledge Agreement (hereinafter this “Agreement”) is dated May 15, 2012, and is entered into in Hangzhou City, People’s Republic of China (“PRC” or “China”) by and among Zhejiang Jiuxin Investment Management Co., Ltd (“Party A” or “Pledgee”), Zhejiang Jiuying Grand Pharmacy Co., Ltd.  (“Party B” or “Company”), each of the individual shareholders listed on the signature pages hereto (i.e. LIU Lei, JIN Chong’an and QI Li, each a “Pledgor” and collectively, “Party C” or the “Pledgors”) of the Company, and Zhejiang Shouantang Medical Technology Co., Ltd (“Party D”).  Party A, Party B, Party C and Party D are each referred to in this Agreement as a “Party” and collectively as the “Parties”. Party D is made a party hereto for the sole purpose of acknowledging this Agreement.

China Jo-Jo Drugstores, Inc. – VOTING RIGHTS PROXY AGREEMENT (May 17th, 2012)

This Voting Rights Proxy Agreement (the “Agreement”) is entered into in Hangzhou, People’s Republic of China (“PRC” or “China”) as of May 15, 2012 by and among Zhejiang Jiuxin Investment Management Co., Ltd (“Party A”) and Zhejiang Jiuying Grand Pharmacy Co., Ltd. (“Company” or “Party B”), the individual shareholders collectively holding 51% of the issued and outstanding equity interests of Party B (i.e. LIU Lei, JIN Chong’an and QI Li, each as a “Individual Shareholder” and collectively as “Party C”), and Zhejiang Shouantang Medical Technology Co., Ltd (“Party D”).  Party A, Party B, Party C and Party D are each referred to in this Agreement as a “Party” and collectively as the “Parties”. Party D is made a party hereto for the sole purpose of acknowledging this Agreement.

China Jo-Jo Drugstores, Inc. – OPERATING AGREEMENT (May 17th, 2012)

This Operating Agreement (this “Agreement”) is dated May 15, 2012, and is entered into in Hangzhou City, People’s Republic of China (“PRC” or “China”) by and among Zhejiang Jiuxin Investment Management Co., Ltd (“Party A”) and Zhejiang Jiuying Grand Pharmacy Co., Ltd.  (“Party B”), the individual shareholders collectively holding 51% of the issued and outstanding equity interests of Party B (i.e. LIU Lei, JIN Chong’an and QI Li, each as a “Individual Shareholder” and collectively as “Party C”), and Zhejiang Shouantang Medical Technology Co., Ltd (“Party D”).  Party A, Party B, Party C and Party D are each referred to in this Agreement as a “Party” and collectively as the “Parties.” Party D is made a party hereto for the sole purpose of acknowledging this Agreement.

China Jo-Jo Drugstores, Inc. – SUPPLEMENTAL AGREEMENT REGARDING EQUITY INTERESTS TRANSFER AGREEMENT (October 21st, 2011)

On April 15, 2011, Transferors and Transferee entered into an Equity Interests Transfer Agreement.  According to such agreement, Transferor WU Shisong shall transfer the 51% equity interests in Zhejiang Jiuxin Medicine Co., Ltd. held by him to Transferee, and Transferor LIU Shan shall transfer the 49% equity interests in Zhejiang Jiuxin Medicine Co., Ltd. to Transferee.  According to such agreement, the total consideration for equity interests to be transferred shall be 50 million Renminbi.  On the execution date of such agreement, Transferors and Transferee jointly applied to the Zhejiang Province Administration of Industry and Commerce to register the transfer of equity interests, including the registration of the Equity Interests Transfer Agreement.  On the same date, the Zhejiang Province Administration of Industry and Commerce approved such registration and issued a new enterprise operating license to Zhejiang Jiuxin Medicine Co., Ltd.  Prior to the execution of this Supplemental

China Jo-Jo Drugstores, Inc. – TRANSFER OF EQUITY INTERESTS AGREEMENT (October 21st, 2011)

Upon amicable negotiations between the Transferors and the Transferee, the two parties hereby reach the following agreements regarding transfer of equity interests of Jiuxin Medicine Co., Ltd from the Transferors to the Transferee:

China Jo-Jo Drugstores, Inc. – CHINA JO-JO DRUGSTORES, INC. Room 507-513, 5th Floor A Building Meidu Plaza Gongshu District, Hangzhou Zhejiang Province, People’s Republic of China Tel: + 86 (571) 88077078 August 1, 2011 (August 2nd, 2011)

China Jo-Jo Drugstores, Inc., a Nevada corporation (the “Company”), is pleased to offer you a non-executive director position on its Board of Directors (the “Board”).  The Board’s purpose is to oversee or direct the property, affairs and business of the Company.